Abbott introduces new DRG Invisible Trial System for chronic pain management

Abbott has announced the launch of the new DRG Invisible Trial System, approved by the US Food and Drug Administration (FDA) and received CE Mark in Europe.

People suffering from complex chronic pain conditions can now use the DRG Invisible Trial System to try Abbott’s dorsal root ganglion (DRG) stimulation—it’s clinically proven, non-opioid treatment option for targeted chronic pain management.

Patients who are relieved with DRG therapy can then have Abbott’s Proclaim DRG system implanted, it empowers them to manage their pain with familiar Apple consumer technology.

Know More

Leave a Reply

Your email address will not be published. Required fields are marked *

Digital Healthcare

Your Health in Your Hand

Technology adoption in Healthcare needs to be prioritized

  There has been a widespread growth in Healthcare Technology, but there is an critical need to adopt them in...

Access to TB Services remains a challenge confirmed by WHO report

There has been steady progress in tackling TB with 9% decrease in incidence seen between 2015 and 2019 and 14%...

Using Sanitizers Frequently Is Safe ?

Sanitizer It is a substance that is applied to hands for removing common disease-causing organisms. It is available in liquid,...

Sleep Recommended

you should note that people’s sleep needs vary – depending on age, health and lifestyle. The quality of their bed,...

Good Sleep; That you all need

Sleep Sleep is an unconscious state of mind and body which is characterized by muscle relaxation and reduced perception of...